Impact of low-density lipoprotein apheresis for nephrotic syndrome in a patient with immunoglobulin M nephropathy

Nephrology (Carlton). 2016 Dec;21(12):1073-1074. doi: 10.1111/nep.12711.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Biomarkers / blood
  • Biopsy
  • Blood Component Removal*
  • Drug Resistance
  • Glomerulonephritis / blood
  • Glomerulonephritis / diagnosis
  • Glomerulonephritis / immunology
  • Glomerulonephritis / therapy*
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunoglobulin M / analysis*
  • Immunohistochemistry
  • Kidney / immunology*
  • Kidney / pathology
  • Lipoproteins, LDL / blood*
  • Male
  • Nephrotic Syndrome / blood
  • Nephrotic Syndrome / diagnosis
  • Nephrotic Syndrome / immunology
  • Nephrotic Syndrome / therapy*
  • Treatment Outcome

Substances

  • Biomarkers
  • Glucocorticoids
  • Immunoglobulin M
  • Lipoproteins, LDL